You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim

Last Updated: April 9, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Sonazoid

Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Sonazoid?

Sonazoid is an investigational drug.

There have been 11 clinical trials for Sonazoid. The most recent clinical trial was a Phase 3 trial, which was initiated on April 1st 2015.

The most common disease conditions in clinical trials are Esophageal Neoplasms, Hypertension, and Heart Failure. The leading clinical trial sponsors are GE Healthcare, Thomas Jefferson University, and National Cancer Institute (NCI).

There are eight hundred and forty-five US patents protecting this investigational drug and seven international patents.

Recent Clinical Trials for Sonazoid
Comparing SonoVue With Sonazoid Using CEUS-LIRADS in HCCSecond Affiliated Hospital, School of Medicine, Zhejiang UniversityPhase 3
Contrast-Enhanced Ultrasound Identification of Sentinel Nodes in Esophageal CancerNational Cancer Institute (NCI)Early Phase 1
Contrast-Enhanced Ultrasound Identification of Sentinel Nodes in Esophageal CancerSidney Kimmel Cancer Center at Thomas Jefferson UniversityEarly Phase 1

See all Sonazoid clinical trials

Clinical Trial Summary for Sonazoid

Top disease conditions for Sonazoid
Top clinical trial sponsors for Sonazoid

See all Sonazoid clinical trials

US Patents for Sonazoid

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Sonazoid   Start Trial Perfluoroalkanes and perfluoroalkane and sulphur hexafluoride compositions as aerosol propellants   Start Trial
Sonazoid   Start Trial Polycarbonate of alkyl cyclohexylidene bisphenol Bayer Aktiengesellschaft (Leverkusen, DE)   Start Trial
Sonazoid   Start Trial Tight binding of proteins to surfaces Washington Research Foundation (Seattle, WA)   Start Trial
Sonazoid   Start Trial Process for the liquid phase chlorination of 1,3-butadiene E. I. Du Pont de Nemours and Company (Wilmington, DE)   Start Trial
Sonazoid   Start Trial Process for preparing flexible polyurethane foam The Dow Chemical Company (Midland, MI)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Sonazoid

Drugname Country Document Number Estimated Expiration Related US Patent
Sonazoid Germany 3926719 2008-12-23   Start Trial
Sonazoid Germany 58903814 2008-12-23   Start Trial
Sonazoid European Patent Office 0374656 2008-12-23   Start Trial
Sonazoid Spain 2053932 2008-12-23   Start Trial
Sonazoid Japan 2931345 2008-12-23   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.